Table 1.
Baseline characteristics FLS population (n = 1042)
| Age (years) | 66.0 (IQR 15) |
| Gender (% females) | 69.0% |
| Length (cm)a | 165.5 (IQR 12) |
| Weight (kg)a | 75.0 (IQR 19.7) |
| BMI (kg/m2)a | 26.8 (IQR 6.2) |
| Fracture (center) (%) | |
| Finger and toe | 11.0% |
| Minor | 54.4% |
| Major | 27.6% |
| Hip | 6.9% |
| BMDb (%) | |
| Normal BMD | 22.8% |
| Osteopenia | 50.8% |
| Osteoporosis | 26.4% |
| Vertebral fractures (VFA)c (%) | |
| At least one grade 1, 2, or 3 (%) | 29.1% |
| At least one grade 2 or 3 (%) | 18.2% |
| Grade 1 | 15.1% |
| Grade 2 | 13.8% |
| Grade 3 | 6.5% |
| Self-reported calcium intake mg/dayd | 780.0 (IQR 387.0) |
| Calcium (mmol/l) | 2.42 (IQR 0.10) |
| Phosphate (mmol/l) | 1.13 (IQR 0.22) |
| Albumin (g/l) | 40 (IQR 4) |
| PTH (pmol/l) | 5.3 (IQR 3.5) |
| Hemoglobin (mmol/l) | 8.5 (IQR 0.9) |
| IgA < 0.2 g/l (%) | 0.19% |
| Anti-tTG IgA > 8 U/ml (%) | 0.38% |
| Vitamin D < 50 nmol/l | 40% |
BMI body mass index, BMD bone mineral density, VFA vertebral fracture assessment, PTH parathyroid hormone, anti-tTG anti-tissue transglutaminase
aData missing of 6 patients
bData missing of 2 patients
cData missing of 3 patients
dData missing of 22 patients